David Wanner, DPM
Podiatrist · Ottumwa, IANPI 1558566208
Payments from drug & device makers
What this record shows
This record is dominated by other: $4,000 of the $5,787 with a category attached, or 69.1%. Acera Surgical, Inc. accounts for 69.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $4,181 and has fallen 99.2% since, to $35 in 2025.
Across 51 payments — averaging $113.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acera Surgical, Inc.$4K
- Kerecis Limited$516
- Reprise Biomedical, Inc.$369
- Organogenesis Inc.$211
- Osiris Therapeutics Inc.$151
- Smith+Nephew$112
- plus $428 from 10 others
What the payments were for
- Food & beverage$1,78731%
- Other$4,00069%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acera Surgical, Inc. | 1 | $4,000 |
| Kerecis Limited | 3 | $516 |
| Reprise Biomedical, Inc. | 6 | $369 |
| Organogenesis Inc. | 6 | $211 |
| Osiris Therapeutics Inc. | 4 | $151 |
| Smith+Nephew | 9 | $112 |
| Zimmer Biomet | 7 | $105 |
| Stryker | 3 | $60 |
| Convatec Inc. | 3 | $56 |
| Johnson & Johnson | 2 | $54 |
| Dynasplint Systems Inc. | 1 | $47 |
| KCI USA, Inc. | 2 | $32 |
| Urgo Medical North America, LLC | 1 | $27 |
| Solventum Corporation | 1 | $19 |
| Vertex | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Restrata Wound Matrix$4,000
- Kerecis Omega3 SurgiClose$1,461
- Kerecis Omega3 GraftGuide$487
- Kerecis Omega3 Marigen$487
- MIRO3D$297
- MiroMiroTract$297
- MIRO3D FIBERS$122
- Stravix$119
- Grafix$119
- GrafixPL$119
How this compares
$5,787 in reported general payments places this provider in the 75th percentile of 94 podiatrist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 80 | $1,225 |
| Pregabalin | 23 | $431 |
| Celecoxib | 24 | $405 |
| Meloxicam | 121 | $355 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $295 |
| Ciclopirox | 11 | $256 |
| Methylprednisolone | 31 | $230 |
| Nabumetone | 11 | $120 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $105 |
| Allopurinol | 30 | $70 |
| Tramadol Hcl | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Ottumwa
- Paul DaytonAnkeny$9.4M
- Mindi DaytonAnkeny$333K
- Eric BarpWest Des Moines$149K
- Travis TidwellWaterloo$33K
- Eric TempleWest Des Moines$19K
- Eric JensenCarroll$17K
- Eric ReeseWest Des Moines$14K
- Andrew StanislavCouncil Bluffs$13K
- Jeffrey KileyCouncil Bluffs$12K
- Ronald KaneWaterloo$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.